-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tazarotene in Idiopathic Pulmonary Fibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tazarotene in Idiopathic Pulmonary Fibrosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tazarotene in Idiopathic Pulmonary Fibrosis Drug Details: GRI-0621 is under...
-
Product Insights
Zentral Imm Boden – Level KS 1 Residential Tower – Styria
The Zentral Imm Boden – Level KS 1 Residential Tower – Styria involves the construction of the Level KS 1 Residential Tower in Gries District, Graz City, Styria State, Austria. Equip yourself with the essential tools needed to make informed and profitable decisions with our Zentral Imm Boden – Level KS 1 Residential Tower – Styria report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days...
-
Product Insights
Gries
Gries is an onshore wind project located in Valais, Switzerland. The project is owned by Grieswind AG and was developed by SwissWinds Development GmbH. The project came online in 2011. Empower your strategies with our Gries report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be...
-
Product Insights
Prado Gris Solar PV Park
Prado Gris Solar PV Park is a solar PV project located in Castile-La Mancha, Spain. The project is owned and being developed by Solarcentury Holdings Ltd. The project is at the permitting stage. Empower your strategies with our Prado Gris Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays....
-
Product Insights
NewPrimary Sclerosing Cholangitis – Drugs In Development, 2024
Empower your strategies with our Primary Sclerosing Cholangitis – Drugs In Development, 2024 report and make more profitable business decisions. Primary sclerosing cholangitis (PSC) is a chronic liver disease characterized by a progressive course of cholestasis with inflammation and fibrosis of the intrahepatic and extra hepatic bile ducts. Symptoms include abdominal pain, chills, diarrhea, fatigue, itchiness, and weight loss. The predisposing factors include age and inflammatory bowel diseases. Treatment includes antibiotics and bile-acid-binding drugs. The Primary Sclerosing Cholangitis drugs in development...
-
Product Insights
NewCholangitis – Drugs In Development, 2024
Empower your strategies with our Cholangitis – Drugs In Development, 2024 report and make more profitable business decisions. Cholangitis refers to inflammation of the bile ducts, which are tubes that carry bile from the liver to the gallbladder and small intestine. This condition can be acute or chronic and is often caused by a bacterial infection or blockage of the bile ducts. Cholangitis can cause a range of symptoms, which may include abdominal pain, particularly in the upper right side; jaundice...
-
Product Insights
NewAttention Deficit Hyperactivity Disorder (ADHD) – Drugs In Development, 2024
Empower your strategies with our Attention Deficit Hyperactivity Disorder (ADHD) – Drugs In Development, 2024 report and make more profitable business decisions. Attention deficit hyperactivity disorder (ADHD) is a group of behavioral symptoms that include inattentiveness, hyperactivity, and impulsiveness. Symptoms of ADHD include disorganized work habits, procrastination, and inability to sustain attention on tasks or activities. Treatment includes analeptics. The Attention Deficit Hyperactivity Disorder (ADHD) drugs in development market research report provide comprehensive information on the therapeutics under development for Attention...
-
Product Insights
Mulilo De Aar Solar PV Park
Mulilo De Aar Solar PV Park is a solar PV project located in Northern Cape, South Africa. The project is owned by GRI Renewable Industries SL; Mulilo Renewable Energy (Pty) Ltd and was developed by GRI Renewable Industries SL; Mulilo Renewable Energy (Pty) Ltd; X-ELIO Energy SL. The project came online in 2014. Empower your strategies with our Mulilo De Aar Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be...
-
Product Insights
Serra Santana II
Serra Santana II is an Onshore Wind project located in Rio Grande do Norte, Brazil. The project is owned by Echoenergia Participacoes SA and was developed by GRI Renewable Industries SL. The project came online in 2015. Empower your strategies with our Serra Santana II report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends...
-
Product Insights
Serra Santana III
Serra Santana III is an Onshore Wind project located in Rio Grande do Norte, Brazil. The project is owned by Echoenergia Participacoes SA and was developed by GRI Renewable Industries SL. The project came online in 2015. Empower your strategies with our Serra Santana III report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends...